OpenLegislation

The Misuse of Drugs (Amendment) (No.2) Regulations (Northern Ireland) 2009

S.R. 2009/397 · Made 30 November 2009

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

This Statutory Rule has been made in consequence of a defect in S.R. 2009 No. 390 and is being issued free of charge to all known recipients of that Statutory Rule.

Dangerous Drugs

Made 30th November 2009

Coming into operation 23rd December 2009

The Department of Health, Social Services and Public Safety makes the following Regulations in exercise of the powers conferred by sections 7, 10, 22 and 31 of the Misuse of Drugs Act 1971f1 as adapted by section 38 of that Act and now vested in itf2.

In accordance with section 31(3) of that Act, it has consulted with the Advisory Council on the Misuse of Drugs.

Annotations to the whole text

Footnotes

f1

1971 c.38 Section 22 of that Act was amended by section 177(1) of, and paragraph 12 of Schedule 4 to, the Customs and Excise Management Act 1979(c.2)

f2

S.R. & O.(N.I) 1973 No 504; Article 5(a) and S.I.1999 /283 (N.I.1), Article 3(6)

Contents

  1. 1Citation and Commencement
  2. 2Interpretation
  3. 3Amendments to the 2002 Regulations
  4. 4Revocation
  5. Signature
  6. Explanatory note

1Citation and Commencement

These Regulations may be cited as the Misuse of Drugs (Amendment) (No.2) Regulations (Northern Ireland) 2009 and shall come into operation on 23rd December 2009.

2Interpretation

(1)

In these Regulations, “the 2002 Regulations” means the Misuse of Drugs Regulations (Northern Ireland) 2002f1

(2)

The Interpretation Act (Northern Ireland) 1954f2 shall apply to these Regulations as it applies to an Act of the Assembly.

3Amendments to the 2002 Regulations

After Regulation 4Af1(exceptions for drugs in Schedule 1) insert—

“Exceptions for gamma–butyrolactone and 1, 4–butanediol

4B
(1)

Gamma–butyrolactone and 1, 4–butanediol are excepted from sections 3(1) (import and export), 4(1) (production and supply) and 5(1) (possession) of the Act save where a person imports, exports, produces, supplies or offers to supply either substance, or has either substance in his possession, knowing or believing that it will be used for the purpose of human ingestion whether by himself or another person other than as a flavouring in food.

(2)

In this regulation references to gamma–butyrolactone and 1, 4–butanediol include—

(a)

any stereoisomeric form of gamma–butyrolactone or 1,4–butanediol;

(b)

any salt of gamma–butyrolactone, 1,4–butanediol or of a substance specified in sub–paragraph (a) of this paragraph; and

(c)

any preparation or other product containing gamma–butyrolactone, 1,4–butanediol or a substance specified in sub–paragraph (a) or (b) of this paragraph.”.

4Revocation

Regulation 4 of the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2009f1 is hereby revoked.

Signature

Sealed with the Official Seal of the Department of Health, Social Services and Public Safety on 30th November 2009

(L.S.)

Christine Jendoubi

A senior officer of the Department of Health, Social Services and Public Safety

Explanatory note

(This note is not part of the Regulations)

These Regulations insert regulation 4B into the Misuse of Drugs Regulations (Northern Ireland) 2002 (“the 2002 Regulations”). They also revoke regulation 4 of the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 2009, which was intended to insert regulation 4B, but which erroneously omitted wording from the text.

Regulation 3 inserts into the 2002 Regulations, regulation 4B. The regulation makes it lawful to import, export, produce, supply, offer to supply or possess Gamma- butyrolactone (GBL) and 1,4 -butanediol (1,4-BD) except where a person does so, knowing or believing that it will be used for the purpose of human ingestion other than as a flavouring in food.